Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Influence of Posture on Airway Diameter, Resistance and Airflow Distribution in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01893697
Recruitment Status : Completed
First Posted : July 9, 2013
Last Update Posted : May 28, 2015
Sponsor:
Information provided by (Responsible Party):
Wilfried De Backer, University Hospital, Antwerp

Brief Summary:
FRI could give the opportunity to investigate the possible effect of a lateral posture on airway diameter and airflow distributions. This physiological study in healthy subjects may help to identify the role of positioning as an aid in airway clearance techniques for patients with respiratory diseases.

Condition or disease Intervention/treatment
Healthy Participants Other: HRCT scan in a specific postural position

Detailed Description:

Many respiratory diseases require a physiotherapeutic treatment that focusses on clearance of excessive mucus from the airways.

The underlying physiological hypothesis why those mucus clearance techniques are effective is based on the development of an optimal expiratory airflow velocity that applies shearing forces on the mucus at the inner surface of the airway. These shearing forces eventually lead to displacement of mucus to the central airways were it could be evacuated.To accomplish optimal velocity with the same expiratory airflow, it is necessary to decrease the airway diameter and hence increase in the airflow velocity. In other words, the airway diameter and resistance are important factors to take into account in mucus clearance techniques.

In many mucus clearance techniques, postural position is used to facilitate this clearance. Clinical trials in patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis where they combined clearance techniques with different postural positions showed to be effective.

The influence of posture has been evaluated in the lateral decubitus position and resulted in a greater clearance of mucus in the depended lung. The authors suggested that this may be due to a better deflation of the depended lung that is favored by 3 forces: gravity, mediastinum weight and pressure of abdominal viscera on the infra lateral lung. Deflation of this lung leads not only to a decrease in lung volume, but also results in a decrease in airway diameter. Nevertheless, it is not known to what extend this decrease in diameter occurs in a lateral position. Furthermore, an optimal expiratory flow must be retained in the underlying lung at lower lung volumes. These regional changes in the underlying lung cannot be measured by for example classic lung function tests since these test are not sensitive enough. Indeed, Washko et. al. found no significant changes of overall residual volume (RV), total lung capacity (TLC) and vital capacity (VC) between the different positions in healthy subject.

However, Functional respiratory imaging (FRI) is able to assess the regional changes in healthy subjects. This 3D imaging technique in combination with computational fluid dynamics (CFD) is accurate in calculating regional changes such as airway diameter, volume and resistance. In addition, repetitive FRI measures are able to assess lobar expansion, which is an indirect measure of airflow distribution in a specific part of the lung.


Layout table for study information
Study Type : Observational
Actual Enrollment : 5 participants
Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: The Influence of Posture on Airway Diameter, Resistance and Airflow Distribution in Healthy Subjects
Study Start Date : April 2013
Actual Primary Completion Date : September 2014
Actual Study Completion Date : September 2014

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Healthy Participants
HRCT scan in a specific postural position
Other: HRCT scan in a specific postural position
HRCT Scan taken in supine and lateral position




Primary Outcome Measures :
  1. Functional Respiratory Imaging [ Time Frame: 1 study visit (1 day) ]
    A low dose 3D spiral high resolution computed tomography (HRCT) scan will be taken on 2 volumes TLC and functional residual capacity (FRC) in both supine and lateral decubitus position. Image post processing is performed to look at local changes in airway or lobar volume [liter] and airway resistance [kiloPascal.seconds/liter] distribution in the lung



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy subjects
Criteria

Inclusion Criteria:

  1. Men or female patients age > 18
  2. No respiratory disease in the days prior to the enrollment
  3. Able to perform a lung function tests
  4. Motivated to participate.
  5. Written informed consent from the subject prior to the participation

Exclusion Criteria:

  1. Serious co-morbidity which would interfere with the examinations
  2. One or multiple CT scans of the chest during the last year.
  3. Deformities or complications preventing patients to maintain side lying position during the scanning procedure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01893697


Locations
Layout table for location information
Belgium
UZA
Antwerp, Edegem, Belgium, 2650
Sponsors and Collaborators
University Hospital, Antwerp
Investigators
Layout table for investigator information
Principal Investigator: Wilfried De Backer, MD PhD University Hospital, Antwerp

Layout table for additonal information
Responsible Party: Wilfried De Backer, Prof. Dr. W De Backer, University Hospital, Antwerp
ClinicalTrials.gov Identifier: NCT01893697     History of Changes
Other Study ID Numbers: RESPT_2013_01
First Posted: July 9, 2013    Key Record Dates
Last Update Posted: May 28, 2015
Last Verified: May 2015